Skip to main content
Future Journal of Pharmaceutical Sciences

Table 11 Tabular representation of percentage wound closure whereas

From: Enhanced therapeutic approach for diabetic foot ulcers: comparative study and characterisation of mupirocin-loaded nanosponge gel with marketed formulation for accelerating wound healing and in vivo evaluation

Days

% Wound closure

NWC

DWC

DW + MP-NSs Gel

DW + MP Ointment

DW + MP-Cream

DW + Becaplermin gel

4

16.2

5.9

24.2

23.3

23.5

25.3

8

31.3

19.4

39.1

35.1

35.8

42.7

12

49.1

24.8

52.7

48.7

49.2

53.4

14

63.7

37.4

71.8

62.5

61.2

78.9

16

73.5

43.1

92.5

79.8

78.7

96.1

  1. NWC Normal wound control, DWC Diabetic wound control, DW Group 1 Diabetic wound treated with mupirocin-loaded nanosponge gel, DW Group 2 Diabetic wound treated with MP-ointment, DW Group 3 Diabetic wound treated with MP-cream, DW Group 4 Diabetic wound treated with Becaplermin gel
Back to article page